We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Stability of hepatitis C virus ( HCV) RNA levels among interferon-naïve HIV/ HCV-coinfected individuals treated with combination antiretroviral therapy Stability of hepatitis C virus ( HCV) RNA levels among interferon-naïve HIV/ HCV-coinfected individuals treated with combination antiretroviral therapy
- Authors
Grint, D; Peters, L; Reekie, J; Soriano, V; Kirk, O; Knysz, B; Suetnov, O; Lazzarin, A; Ledergerber, B; Rockstroh, JK; Mocroft, A
- Abstract
Objectives Infection with hepatitis C virus ( HCV) is a major cause of chronic liver disease. High HCV RNA levels have been associated with poor treatment response. This study aimed to examine the natural history of HCV RNA in chronically HCV/ HIV-coinfected individuals. Methods Mixed models were used to analyse the natural history of HCV RNA changes over time in HIV-positive patients with chronic HCV infection. Results A total of 1541 individuals, predominantly White (91%), male (73%), from southern (35%) and western central Europe (23%) and with HCV genotype 1 (58%), were included in the analysis. The median follow-up time was 5.0 years [interquartile range ( IQR) 2.8 to 8.3 years]. Among patients not on combination antiretroviral therapy ( cART), HCV RNA levels increased by a mean 27.6% per year [95% confidence interval ( CI) 6.1−53.5%; P = 0.0098]. Among patients receiving cART, HCV RNA levels were stable, increasing by a mean 2.6% per year (95% CI −1.1 to 6.5%; P = 0.17). Baseline HCV RNA levels were 25.5% higher (95% CI 8.8 to 39.1%; P = 0.0044) in individuals with HCV genotype 1 compared with HCV genotypes 2, 3 and 4. A 1 log HIV-1 RNA copies/mL increase in HIV RNA was associated with a 10.9% increase (95% CI 2.3 to 20.2%; P = 0.012) in HCV RNA. Conclusions While HCV RNA levels increased significantly in patients prior to receiving cART, among those treated with cART HCV RNA levels remained stable over time.
- Subjects
CONFIDENCE intervals; GENES; HIV infections; LONGITUDINAL method; SCIENTIFIC observation; HEALTH outcome assessment; REGRESSION analysis; RESEARCH funding; RNA; ANTIRETROVIRAL agents; MULTIPLE regression analysis; TREATMENT effectiveness; DATA analysis software; STATISTICAL models; CHRONIC hepatitis C; PHARMACODYNAMICS
- Publication
HIV Medicine, 2013, Vol 14, Issue 6, p370
- ISSN
1464-2662
- Publication type
Article
- DOI
10.1111/hiv.12033